Medication use in a large international sample of people with multiple sclerosis: associations with quality of life, relapse rate and disability

Clinically Significant Fatigue: Prevalence and Associated Factors in an International Sample of Adults with Multiple Sclerosis Recruited via the Internet

(2015) Tracey J. Weiland et al.   PLoS One

Lifestyle factors, demographics and medications associated with depression risk in an international sample of people with multiple sclerosis

(2014) Keryn L Taylor et al.   BMC Psychiatry

A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial

(2014) Tjalf Ziemssen et al.   JOURNAL OF NEUROLOGY

Polypharmacy in multiple sclerosis: Relationship with fatigue, perceived cognition, and objective cognitive performance

(2014) Joanie M Thelen et al.   JOURNAL OF PSYCHOSOMATIC RESEARCH

Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies

(2014) Dean M. Wingerchuk et al.   MAYO CLINIC PROCEEDINGS

Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis

(2013) Omar Khan et al.   ANNALS OF NEUROLOGY

Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing–remitting multiple sclerosis: The DEFINE study

(2013) Ludwig Kappos et al.   Multiple Sclerosis Journal

Efficacy of Modafinil on Fatigue and Excessive Daytime Sleepiness Associated with Neurological Disorders: A Systematic Review and Meta-Analysis

(2013) Ping Sheng et al.   PLoS One

Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis

(2012) Afsaneh Shirani et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Disease-modifying agents in multiple sclerosis

(2009) PK Coyle   Annals of Indian Academy of Neurology

Real-life impact of early interferonβ therapy in relapsing multiple sclerosis

(2009) M. Trojano et al.   ANNALS OF NEUROLOGY

SEVERE CARDIAC FAILURE IN A PATIENT WITH MULTIPLE SCLEROSIS FOLLOWING LOW-DOSE MITOXANTRONE TREATMENT

(2009) J. Dorr et al.   NEUROLOGY

Benefits of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis

(2009) Kenneth P Johnson et al.   Expert Review of Pharmacoeconomics & Outcomes Research

Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey

(2008) Olympia Hadjimichael et al.   Health and Quality of Life Outcomes

The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis

(2008) DK Tepavcevic et al.   Multiple Sclerosis Journal